Randomized Controlled Trial of Stress Management Training in HIV

NCT00436085 | Completed Phase 3

• 1 other identifier: 3346C0-100907
• Study Type: interventional
• Target: 100
• Locations: 1 country
• Sites: 1

Brief Summary

The introduction of highly active antiretroviral therapy (HAART) has dramatically changed the consequences of an HIV infection, which is now viewed as a chronic disease. As in other chronic diseases, emotional distress and depressive symptoms are highly prevalent in HIV-infected patients. Psychological factors such as these have been associated with lower quality of life, lower adherence to therapy and also with a higher risk for mortality and disease progression. Psychosocial interventions, such as group-based cognitive behavioral stress management (CBSM) training, have been shown to reduce distress and psychological symptoms in HIV-infected patients. These psychosocial effects are paralleled by changes in physiological parameters, such as cortisol, DHEA-S, testosterones, catecholamines, and naïve T-cell counts. While these results are congruent with recent evidence of the interaction between psychological, neuroendocrine and immunological parameters in HIV-infected patients, it needs to be shown whether the reported effects hold true in the HAART era. Most importantly, it also needs to be ascertained whether these interventions have an impact on immunological and virological HIV parameters as well as on mortality and morbidity in HIV patients. We propose a randomized controlled one-year prospective evaluation of a group-based CBSM training in 80 HIV-infected patients. Participating patients will be recruited at cooperating centers of the Swiss HIV Cohort Study and randomly assigned to CBSM training or waiting control group condition. At baseline, post-training and two follow-up (6 and 12 months) assessments, effects of the CBSM on psychological, physiological and clinical out-come variables in HIV-infected patients under HAART will be evaluated. Additionally, the effects of CBSM on the neuroendocrine and autonomic stress reactivity in HIV-infected patients will be assessed, thus evaluating a possible direct pathway between emotional distress and physiological HIV-relevant parameters. In conclusion, the planned research project evaluates the effectiveness of a standardized psychosocial intervention as a possible component of a comprehensive disease management in HIV-infected patients under HAART.

Conditions

HIV Infections

Outcome Measures

Primary Outcomes (2)

• CD4 cell count

• HIV viral load

Secondary Outcomes (2)

• Depression and Anxiety

• QUality of life

Interventions

Cognitive behavioral stress management training BEHAVIORAL

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Adults between 18 and 65 years of age
• Sufficient German-speaking abilities to participate in group therapy
• cARTwithin the previous three months,
• CD4 lymphocyte count above 100 cells/mL

You may not qualify if:

• Active opportunistic infection at baseline
• Formal psychotherapy within the previous three months
• Intravenous drug users
• Diagnosable current major psychiatric disorder (bipolar affective disorder, psychotic disorders, major depression with melancholia) and diagnosis of antisocial and borderline personality disorders at baseline

Sponsors & Collaborators

• University of Zurich: lead
• Swiss National Science Foundation: collaborator

Study Sites (1)

University Hospital Zurich

Zurich, 8006, Switzerland

Location

MeSH Terms

Conditions

HIV Infections

Condition Hierarchy (Ancestors)

Blood-Borne Infections; Communicable Diseases; Infections; Sexually Transmitted Diseases, Viral; Sexually Transmitted Diseases; Lentivirus Infections; Retroviridae Infections; RNA Virus Infections; Virus Diseases; Genital Diseases; Urogenital Diseases; Immunologic Deficiency Syndromes; Immune System Diseases

Study Officials

• Jens Gaab, PhD

  Clinical Psychology and PSychotherapy, Institute of Psychology, University of Zürich

  PRINCIPAL INVESTIGATOR

• Rainer Weber, MD

  University Hospital, Zürich

  PRINCIPAL INVESTIGATOR

• Ulrike Ehlert, PhD

  Clinical Psychology and Psychotherapy, Institute of Psychology, University of Zurich

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: phase 3
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER

Study Record Dates

• First Submitted: February 15, 2007
• First Posted: February 16, 2007
• Study Start: December 1, 2003
• Study Completion: December 1, 2005
• Last Updated: February 16, 2007

Record last verified: 2007-02

Locations

CH (1)